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Addressing prescription discrepancies in renal 
patients: a prospective audit
S Lam1, S Docherty2, JE Taylor3
Background Management of chronic renal failure requires complex 
medication regimens to manage hypertension, hyperlipidaemia, diabetes, 
phosphate, anaemia and acidosis. Patient engagement in medicine 
management is essential to avoid potential harm. 
Methods We prospectively audited the rate of discrepancies between our 
hospital record of patient medications and their current prescription. We investigated whether 
changes to appointment letters reduced the number of discrepancies.
Results The proportion of patients attending renal outpatient clinics failing to bring a list or 
unable to recall their medications fell over a 3-year period following changes to appointment 
letters (median proportion: 0.45 in 2014, 0.36 in 2015, 0.30 in 2016, Chi-sq = 46.94, p 
< 0.001); percentage of patients forgetting to bring a list with signi cant prescription 
discrepancies fell from 10.9% in 2014 to 3.9% in 2016).
Conclusion Changes to appointment letters can potentially improve prescribing safety in an 
outpatient setting. 
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Abstract
Introduction
Renal patients often have a complicated medical history 
necessitating frequent changes in medications and dosage. 
When they are seen in outpatient clinics it is imperative 
to have an up to date list of medications that, taken in 
combination with blood results and physical examination, 
facilitates accurate assessment of response to current 
treatment and determines future treatment plans.
Current methods to retrieve an up to date list of medications 
include contacting the GP, checking the renal records of 
the medications that the patient was taking at the last 
outpatient clinic, and asking the patient. One of the most 
reliable methods when reconciling medications is through 
a pharmacist who clariﬁ es the current prescription with the 
patient’s community pharmacy, and looks at recent orders of 
medications.1 Nester et al. studied the impact of medicines 
reconciliation with and without the contributory work of a 
pharmacist,1 and demonstrated that when a pharmacist was 
involved, more prescription discrepancies were found between 
what the patient was actually taking and the initial hospital 
record. Another study looked at the potential harm that could 
have occurred as a result of prescription discrepancies.2 In 
this study, 22% of the discrepancies could have resulted in 
harm during hospitalisation, and 59% could have caused 
patient harm if the error was continued beyond discharge.2 
These studies show that involvement of a pharmacist in 
obtaining an accurate drug history is beneﬁ cial. However, 
similar support in an outpatient setting is often not available 
due to time constraints and cost. The quickest and most 
reliable way of obtaining an accurate drug history is to ask 
the patient directly. But this method is only reliable if the 
patient is prepared with a current medication list or is able 
to accurately recall their medications. 
This prospective audit aimed to assess the accuracy of 
hospital records of patient prescriptions and investigate 
whether changes to appointment letters could improve the 
accuracy of documentation.
Method
Over the course of three years, data were collected on all 
patients attending renal clinic appointments at Dorset County 
Hospital, Poole Hospital, the Royal Bournemouth Hospital, 
and Yeovil Hospital. Since all patients were seen by a single 
renal consultant, these data were pooled for the purposes 
of this audit and biases towards any particular patient group 
were therefore reduced. Patients were a mixture of general 
nephrology, pre-dialysis, and renal replacement therapy 
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(haemodialysis, peritoneal dialysis and post-transplant), 
from an area generally covering a rural, higher socioeconomic 
class and elderly population. Data were not collected when 
a patient failed to attend their outpatient appointment. Data 
were recorded according to whether a patient had brought 
a copy of their repeat prescription to clinic and, if they did 
not, whether they could accurately recall their medications 
(as judged by the physician in clinic – patients on under 
three drugs). If they did not bring a list and could not recall 
their medications, the patient’s GP surgery was contacted 
during the clinic appointment for an accurate list of drugs 
actually being received by the patient. The dependent variable 
measured was the number of discrepancies between GP 
prescribing and the hospital record. 
Data collection started in January 2014. The ﬁ rst intervention 
(ﬁ rst independent variable) was initiated in February 2014 
where the clinic appointment letters were changed to include 
a reminder for patients to bring a copy of their repeat 
prescription. On the letter the following text was added: 
‘Please can you bring your GP prescription for medication 
with you to every clinic visit. This provides the doctor with 
essential information about the medication that you are 
taking’. In August 2014 the second intervention (second 
independent variable) highlighting this message in bold, 
was applied. Because patient follow up varied from bi-weekly 
to once a year, data were collected over a 3-year period to 
monitor discrepancy levels following the changes to the letter. 
It is routine policy in our unit for all patients to receive a copy 
of their clinic letters. 
The proportion of patients presenting without a copy of their 
repeat prescription was calculated per clinic by dividing the 
number of patients falling into this category by the total 
number of patients attending that clinic session. Since 
data were not normally distributed, descriptive statistics 
are reported as median with the range of the data, and the 
Kruskal-Wallis test was used to look for differences between 
periods before and after letter changes as well as between 
years of data collection. All analyses were performed using 
IBM SPSS Statistics version 24.
Results
A total of 1975 patients were seen in 2014 (271 new 
patients, 1704 follow up patients) in 168 clinic sessions. 
During 2015, 1902 patients (185/1717) were seen in 163 
clinic sessions, and 1886 patients (231/1655) in 165 
sessions during 2016. All patients who attended clinic were 
eligible for the study. The overall non-attendance percentage 
for renal clinics in our unit was 7.3% in 2014, 5.6% in 2015, 
and 5.5% in 2016.
Short term changes in list presentation
A comparison of data before, during and after the letter 
changes in 2014 (Table 1), revealed the only measure 
showing a significant difference was mean number of 
discrepancies per GP list patient (Chi-square = 8.64, p = 
0.01). However, this change represented an increase in the 
number of discrepancies from a median of 1 to 2 per patient 
following the ﬁ rst letter change.
Longer term changes in list presentation
Longer term changes in list presentation were made using 
yearly comparisons. The proportion of patients bringing their 
repeat prescription to their clinic appointment increased 
from 0.55 to 0.70 between 2014 and 2016 (Table 2). This 
resulted in a decrease in the number of patients requiring 
list conﬁ rmation from their GP.
The percentage of total patients forgetting to bring their 
list of medication to clinic and who could not recall their 
medications either, where checking with the GP revealed 
signiﬁ cant discrepancies between what the patient was taking 
and what they had been prescribed, fell from 10.5 % in 2014 
to 8.9% in 2015 and to 3.9% in 2016 (Figure 1).
Discussion
This prospective audit demonstrated discrepancies between 
hospital records and what the patient actually takes. Changing 
clinic appointment letters to remind patients to bring a list 
of their current prescription may reduce drug discrepancies 
Table 1 Analysis of patients bringing list of medication to 
appointments during 2014
Pre-
intervention 
(Jan 2014)
Letter 
change 1
(Feb 2014)
Letter 
change 2
(Aug 2014)
Proportion of 
patients bringing 
list
0.54
(0.58)
0.54
(0.80)
0.57
(0.83)
Proportion 
of patients 
requiring list 
conﬁ rmation 
from GP
0.10
(0.27)
0.13
(0.44)
0.14
(0.67)
Proportion of 
patients whose 
GP list has 
discrepancies
1.00
(1.00)
0.88
(1.00)
0.67
(1.00)
Mean number 
of discrepancies 
per GP list 
patient
1.00
(5.50)
2.00
(7.00)
1.00
(7.00)
• Reported statistics are median and (range) as data were not 
normally distributed
• Proportion of patients bringing list = number of patients bringing 
list/total number of patients seen for that clinic session
• Proportion  of patients requiring list conﬁ rmation from GP = 
number of patients not bringing list with no recall of meds/total 
number of patients seen for that clinic session
• Proportion of patients whose GP list has discrepancies = number 
of patients with discrepancies/total number of patients not 
bringing list with no recall of medications for that clinic session
• Mean number of discrepancies per GP list patient = total number 
of list discrepancies/number of patients with discrepancies
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in an outpatient setting, and could potentially enable safer 
prescribing. Also, time during clinic is saved, as it is not spent 
searching for a drug history. Determining accurate medicine 
history may facilitate discussion around adherence issues.
Discrepancies between GP and renal records suggest that 
changes to medication are not always being recorded on 
different systems simultaneously. Kaboli et al. found that 
very few computerised records are accurate (5.3% in 493 
patients over the age of 65).3 Other studies demonstrate 
that even when prescription discrepancies were found, 
drug record systems were not consistently being updated.4 
Staroselsky et al. investigated whether empowering patients 
with the responsibility to update their own drug records would 
improve accuracy.4 Patients were given access to a secure 
portal of their drug records and were able to request update 
of any incorrect information.4 There was no difference in 
prescription discrepancies between patients who notiﬁ ed 
their doctor more frequently of drug history changes.4 One 
of the main reasons for this was failure of doctors to update 
the electronic prescription system.4
Other methods implemented to improve accuracy of 
medicine reconciliation include educating patients about 
their medicines. In England, community pharmacists have 
been encouraged to perform medication use reviews with 
patients to improve medication compliance.5 The impact of 
medicine use reviews in reducing drug discrepancies on GP 
records is unknown.5 Pharmacists commented they receive 
little feedback from GPs about any prescription discrepancies 
they have discovered.5 This highlights that despite medicine 
reconciliation, the main drug record system may not be 
updated and prescription discrepancies remain. 
Stewart et al. showed that using an electronic medical record 
and a pharmacist performing medication reconciliation with 
the patient prior to seeing a doctor reduced prescription 
discrepancies, but not completely.6 They found that 
discrepancies remained during follow up consultations 
because of drug omissions or unreported over-the-counter 
drugs.6 It is unclear from the study whether drug omissions 
were due to patient or doctor decisions. They suggested that 
discrepancies can arise between what the patient actually 
takes and what the doctor has prescribed despite the 
medicines being on a repeat prescription.6
Our study did not investigate the type of drugs subject 
to discrepancies, except they were all prescribed drugs 
Figure 1 Proportion of patients 
with list discrepancies over the 
audit period compared to the 
mean for the period preceding 
the second letter change 
(January–August 2014).
2014 2015 2016
Proportion of 
patients bringing list
0.55
(0.83)
0.64
(0.82)
0.70
(0.75)
Chi-sq = 46.94
p < 0.001
Proportion of 
patients requiring 
list conﬁ rmation 
from GP
0.13
(0.67)
0.10
(0.50)
0.08
(0.38)
Chi-sq = 39.35
p < 0.001
Proportion of 
patients whose 
GP list has 
discrepancies
0.75
(1.00)
0.75
(1.00)
0.00
(1.00)
Chi-sq = 35.86
p < 0.001
Mean number of 
discrepancies per 
GP list patient
1.42
(7.00)
1.50
(8.00)
0.00
(5.00)
Chi-sq = 36.92
p < 0.001
Reported statistics are median and (range). All measures showed a signiﬁ cant change across the 
years (p < 0.05)
Table 2 Comparative analysis 
of patients bringing list of med-
ication to appointments during 
2014, 2015 and 2016
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rather than over-the-counter preparations. Neither did we 
investigate any impact of age, sex, and comorbidities. It 
would be interesting to gather further data regarding how 
many of these drug discrepancies were due to patients 
choosing to discontinue a prescribed medication, or true dose 
discrepancies, because checking with GP surgeries in some 
cases identiﬁ ed that patients were not actually receiving 
some of their prescribed medications. 
Leonhardt et al. interviewed patients to investigate the 
reasons why they were unable to recall the medications 
they took.7 Answers included patients thinking the doctor 
already had a medication list, and some were afraid to ask 
the doctor when they didn’t understand what medication 
they were taking.7 It could be useful to conduct interviews/
questionnaires for patients to search for possible human 
factors behind why patients do not bring their medication list 
or cannot recall the medications they take. 
McLean et al.’s study showed that text messages reminding 
patients of their appointment increases attendance.8 A 
similar method may also improve the number of patients 
bringing a prescription list to clinic. In our clinics patients 
are texted to remind them of their appointments, subject to 
their agreement to receiving texted reminders. This study did 
not look at the difference in drug discrepancies in patients 
who had received both a text and letter reminder compared 
to those only receiving a letter; a further study looking at 
whether these independent variables affect the number of 
drug prescription discrepancies would be interesting. Other 
digital aids such as smartphone apps and ‘Renal Patient 
View’ may assist some patients but this may not be available 
to all, especially those who do not have the skills or means to 
access smartphones and computers. The planned universal 
introduction of the NHS Digital Summary Care Record could 
resolve most issues around medication discrepancies, 
especially as this system also enables medication 
dispensation to be viewed. However it is not available to all 
NHS organisations at present, requires smart card access, 
and current digital systems can make information retrieval 
limited and time-consuming. Improvements in data access 
systems and IT hardware across the NHS are planned, but 
not all GP surgeries and patients are willing to sign up to 
this service so there will always be a need for more direct 
checks in some cases.
Conclusion 
This prospective audit has demonstrated a reduction in 
prescription discrepancies in a renal outpatient clinic 
following the introduction of a message on the appointment 
letter asking patients to bring a medication list. Further 
studies addressing human factors and the types of drug 
discrepancies may provide insight into why drug discrepancies 
remain. The introduction of the NHS Digital Summary Care 
Record should resolve most issues around medication 
discrepancies; although in a minority of cases direct checking 
of patient medicines may still be required. 
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